SEC Form 3 · accession 0000899243-19-003482
TCR2 THERAPEUTICS INC. · TCRR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Baeuerle
Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 13, 2019 · 6:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001750019
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F4 | holding | — | — | — | 244,878 | I | By APAK Solutions GmbH | |
| Common StockF2,F4 | holding | — | — | — | 53,452 | I | By APAK Solutions GmbH | |
| Common StockF3,F4 | holding | — | — | — | 169,385 | I | By APAK Solutions GmbH |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are subject to a Stock Restriction Agreement dated June 1, 2015. The shares subject to the Stock Restriction Agreement shall vest in 48 equal monthly installments beginning on June 1, 2015.
- F2The shares are subject to a Stock Restriction Agreement dated May 9, 2017. The shares subject to the Stock Restriction Agreement shall vest in 36 equal monthly installments beginning on December 13, 2016.
- F3The shares are subject to a Stock Restriction Agreement dated December 15, 2017. 25% of the shares vested on the first anniversary of the vesting start date of December 6, 2016, with the remainder vesting in 36 equal quarterly installments thereafter.
- F4The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
Remarks
Exhibit 24.1: Power of Attorney